What is Teknova?
Founded in 1996 and headquartered in Hollister, California, Teknova serves as a foundational pillar for the healthcare and life sciences industries. The company specializes in the manufacturing of essential reagents, including cell culture media, protein purification buffers, and molecular biology tools. These products are vital for bioproduction workflows, enabling researchers and manufacturers to maintain consistency and efficiency in complex biological processes. Teknova's long-standing operational history provides it with a competitive moat, as it supports the critical supply chain requirements of modern biotechnology and diagnostic development.
How much funding has Teknova raised?
Teknova has raised a total of $96M across 1 funding round:
Stock Offering
$96M
Stock Issuance/Offering (2021): $96M, investors not publicly disclosed
Key Investors in Teknova
Undisclosed Investors
Undisclosed Investors
Undisclosed Investors
What's next for Teknova?
With the successful completion of this major enterprise-level funding, Teknova is positioned to accelerate its strategic growth initiatives. The company is expected to focus on expanding its manufacturing footprint and enhancing its R&D capabilities to address the evolving needs of the bioprocessing market. As the industry shifts toward more complex therapeutic modalities, Teknova's ability to provide reliable, high-purity reagents will be a key driver of its future performance. Investors and industry analysts will be monitoring how the firm leverages this capital to capture additional market share in the rapidly growing molecular diagnostics space.
See full Teknova company page
